Drug Regimen with Short Pauses Controls HIV and Could Lower Costs, Toxicity

Blog.AIDS.gov: "A clinical trial in Uganda has found that pausing antiretroviral therapy (ART) for just two days every week is at least as effective as taking ART continuously over a 72-week period. In addition, the intermittent regimen was associated with less drug toxicity relative to continuous ART. These findings, reported on April 22 in PLoS ONE, may have implications for increasing the number of HIV-infected individuals on ART in resource-limited settings."